10.21147/j.issn.1000-9604.2016.02.07
Phase Ⅰ study of chimeric anti-CD20 monoclonal antibody in Chinese patients with CD20-positive non-Hodgkin”s lymphoma
Chinese patients
28
R6
This work was supported in part by Chinese National Major Project for New Drug Innovation2008ZX09312-020,2009ZX09503-014,2012ZX09303012 and 2013ZX09402301;National Key Technology Support Program2014BAI09B12;Beijing Municipal Science and Technology Commission Major Project for New Drug InnovationZ111102071011001;Beijing Municipal Science and Technology Commission Project for Beijing Key LaboratoryZ121102009212055
2016-06-02(万方平台首次上网日期,不代表论文的发表时间)
共12页
197-208